Philadelphia, USA; Shanghai, China; and Verona, Italy. March 01, 2023 – ClinChoice Medical Development is pleased to announce its acquisition of CROMSOURCE S.r.l., an ISO-certified full-service contract research organization with its corporate headquarters in Verona, Italy and its US headquarters in Cary, NC. CROMSOURCE has operational subsidiaries in the US and seven countries throughout Western … Continued
ClinChoice Raises $150 mm Series E Round Financing, Further Strengthening its Global Services Capabilities PHILADELPHIA, July 5, 2022 /PRNewswire/ — Recently, ClinChoice announced the successful completion of its $150 mm Series E round financing. The investment was led by Legend Capital, and co-invested by Taikang Life Insurance, Sherpa Healthcare Partners and existing shareholders, including Lilly Asia Ventures and Apricot … Continued
Depth and diversity of Calyx scientific and technical teams’ experience extended to ClinChoice’s worldwide clients NOTTINGHAM, England and MORRISVILLE, N.C., March 7, 2022 /PRNewswire/ — Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, today announced it has been named a preferred provider of medical … Continued
ClinChoice Opens Canadian Development Center – Expanding its North American Capabilities PHILADELPHIA and SHANGHAI, July 22, 2021 /PRNewswire/ — ClinChoice, a leading global, midsize, and rapidly growing contract research organization (CRO) focused on the delivery of superior quality, highly efficient, and effective clinical research services across the development continuum in Pharmaceutics, Vaccines, Medical Devices, Consumer … Continued
